Related references
Note: Only part of the references are listed.Eradication of HIV from the brain: reasons for pause
Avindra Nath et al.
AIDS (2011)
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy
Hiromi Imamichi et al.
AIDS (2011)
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
Marlene Smurzynski et al.
AIDS (2011)
Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2
Gero Huetter et al.
AIDS (2011)
Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension
Mark G. Lewis et al.
AIDS (2011)
Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy
Duncan Chege et al.
AIDS (2011)
HIV cure and eradication: how will we get from the laboratory to effective clinical trials?
Sharon R. Lewin et al.
AIDS (2011)
Eradication Therapies for HIV Infection: Time to Begin Again
David M. Margolis
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
Thirty Years of HIV and AIDS: Future Challenges and Opportunities
Carl W. Dieffenbach et al.
ANNALS OF INTERNAL MEDICINE (2011)
Curing HIV: Pharmacologic Approaches to Target HIV-1 Latency
Shailesh K. Choudhary et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Single Mutations in HIV Integrase Confer High-Level Resistance to Raltegravir in Primary Human Macrophages
Matthew D. Marsden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
Kristina Allers et al.
BLOOD (2011)
Responsiveness of HIV-specific CD4 T cells to PD-1 blockade
Filippos Porichis et al.
BLOOD (2011)
Profaning the Ultimate Sanctuary: HIV Latency in Hematopoietic Stem Cells
Didier Trono et al.
CELL HOST & MICROBE (2011)
HIV-1 Utilizes the CXCR4 Chemokine Receptor to Infect Multipotent Hematopoietic Stem and Progenitor Cells
Christoph C. Carter et al.
CELL HOST & MICROBE (2011)
Targeted Disruption of the CCR5 Gene in Human Hematopoietic Stem Cells Stimulated by Peptide Nucleic Acids
Erica B. Schleifman et al.
CHEMISTRY & BIOLOGY (2011)
Wounding the Immune System with its Own Blade: HIV-Induced Tryptophan Catabolism and Pathogenesis
A. Boasso
CURRENT MEDICINAL CHEMISTRY (2011)
Potential Strategies for an HIV Infection Cure
Alain Lafeuillade
HIV CLINICAL TRIALS (2011)
A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
Hiroyu Hatano et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation
Sifei Xing et al.
JOURNAL OF VIROLOGY (2011)
Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4+ T Cells
Jeffrey A. Anderson et al.
JOURNAL OF VIROLOGY (2011)
The Gut Mucosal Viral Reservoir in HIV-Infected Patients Is Not the Major Source of Rebound Plasma Viremia following Interruption of Highly Active Antiretroviral Therapy
Paula Lerner et al.
JOURNAL OF VIROLOGY (2011)
Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir
Shay Matalon et al.
MOLECULAR MEDICINE (2011)
Nanoparticles Deliver Triplex-forming PNAs for Site-specific Genomic Recombination in CD34(+) Human Hematopoietic Progenitors
Nicole A. McNeer et al.
MOLECULAR THERAPY (2011)
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
Alex Sigal et al.
NATURE (2011)
Activation of Latent HIV Using Drug-Loaded Nanoparticles
Michael Kovochich et al.
PLOS ONE (2011)
HIV/AIDS RESEARCH Tissue Says Blood Is Misleading, Confusing HIV Cure Efforts
Jon Cohen
SCIENCE (2011)
Patients on HAART often have an excess of unintegrated HIV DNA: Implications for monitoring reservoirs
Luis M. Agosto et al.
VIROLOGY (2011)
Macrophages and HIV-1
Viviana Cobos-Jimenez et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Introduction: challenges to finding a cure for HIV infection
Douglas D. Richman
CURRENT OPINION IN HIV AND AIDS (2011)
Targeting viral reservoirs: ability of antiretroviral therapy to stop viral replication
Frank Maldarelli
CURRENT OPINION IN HIV AND AIDS (2011)
Maintenance of CD4(+) T-cell memory and HIV persistence: keeping memory, keeping HIV
Nicolas Chomont et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Elite controllers as a model of functional cure
Brigitte Autran et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Histone deacetylase inhibitors and HIV latency
David M. Margolis
CURRENT OPINION IN HIV AND AIDS (2011)
Functional Cure of SIVagm Infection in Rhesus Macaques Results in Complete Recovery of CD4+ T Cells and Is Reverted by CD8+ Cell Depletion
Ivona Pandrea et al.
PLOS PATHOGENS (2011)
Homeostatic Proliferation Fails to Efficiently Reactivate HIV-1 Latently Infected Central Memory CD4+T Cells
Alberto Bosque et al.
PLOS PATHOGENS (2011)
Elite Suppressors Harbor Low Levels of Integrated HIV DNA and High Levels of 2-LTR Circular HIV DNA Compared to HIV plus Patients On and Off HAART
Erin H. Graf et al.
PLOS PATHOGENS (2011)
Episomal Viral cDNAs Identify a Reservoir That Fuels Viral Rebound after Treatment Interruption and That Contributes to Treatment Failure
Mark Sharkey et al.
PLOS PATHOGENS (2011)
Gene Therapy Strategies: Can We Eradicate HIV?
Jan van Lunzen et al.
Current HIV/AIDS Reports (2011)
Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1
Byeong-Sun Choi et al.
AIDS (2010)
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
Steven A. Yukl et al.
AIDS (2010)
Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
Laurent Hocqueloux et al.
AIDS (2010)
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Tae-Wook Chun et al.
AIDS (2010)
Achieving a Quantitative Understanding of Antiretroviral Drug Efficacy
Lin Shen et al.
CLINICAL INFECTIOUS DISEASES (2010)
Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy
D. McMahon et al.
CLINICAL INFECTIOUS DISEASES (2010)
Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency
Moises Perez et al.
CURRENT HIV RESEARCH (2010)
Can HIV infection be eradicated through use of potent antiviral agents?
Lina Josefsson et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Minocycline Attenuates HIV Infection and Reactivation by Suppressing Cellular Activation in Human CD4+ T Cells
Gregory L. Szeto et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Differences in HIV Burden and Immune Activation within the Gut of HIV-Positive Patients Receiving Suppressive Antiretroviral Therapy
Steven A. Yukl et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+T lymphocytes
Laetitia Redel et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Combinatorial Latency Reactivation for HIV-1 Subtypes and Variants
John C. Burnett et al.
JOURNAL OF VIROLOGY (2010)
Can HIV be cured with stem cell therapy?
Steven G. Deeks et al.
NATURE BIOTECHNOLOGY (2010)
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
Nathalia Holt et al.
NATURE BIOTECHNOLOGY (2010)
New tools to track HIV
Timothy Schacker
NATURE MEDICINE (2010)
The enemy within: dormant retroviruses awaken
Michael E. Engel et al.
NATURE MEDICINE (2010)
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs
Christoph C. Carter et al.
NATURE MEDICINE (2010)
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Maria J. Buzon et al.
NATURE MEDICINE (2010)
HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
Didier Trono et al.
SCIENCE (2010)
Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease
David Favre et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
RNA-Based Gene Therapy for HIV With Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
David L. DiGiusto et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Therapy for persistent HIV
Kara S. Keedy et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Immunotoxin Complementation of HAART to Deplete Persisting HIV-Infected Cell Reservoirs
Edward A. Berger et al.
PLOS PATHOGENS (2010)
Specific eradication of HIV-1 from infected cultured cells
Aviad Levin et al.
AIDS RESEARCH AND THERAPY (2010)
Mechanisms of HIV Latency: an Emerging Picture of Complexity
David M. Margolis
Current HIV/AIDS Reports (2010)
The immune response during acute HIV-1 infection: clues for vaccine development
Andrew J. McMichael et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Emerging Concepts in the Immunopathogenesis of AIDS
Daniel C. Douek et al.
ANNUAL REVIEW OF MEDICINE (2009)
Pharmaceutical approaches to eradication of persistent HIV infection
Mary-Catherine Bowman et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Multidrug-Resistant Variants of HIV Type 1 (HIV-1) Can Exist in Cells as Defective Quasispecies and Be Rescued by Superinfection with Other Defective HIV-1 Variants
Yudong Quan et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4+ T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy
Timothy P. Brennan et al.
JOURNAL OF VIROLOGY (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips
Libin Rong et al.
MATHEMATICAL BIOSCIENCES (2009)
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
Mayte Coiras et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Detecting HIV-1 integration by repetitive-sampling (Alu)under-bar-gag PCR
Megan K. Liszewski et al.
METHODS (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies
Laurence Colin et al.
RETROVIROLOGY (2009)
The Challenge of Finding a Cure for HIV Infection
Douglas D. Richman et al.
SCIENCE (2009)
HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors
Veronique Avettand-Fenoel et al.
AIDS (2008)
Relationship between T cell activation and CD4(+) T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
Lin Shen et al.
NATURE MEDICINE (2008)
IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART
FX Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Share Paper
